Search

Your search keyword '"de Kruijf EM"' showing total 23 results

Search Constraints

Start Over You searched for: Author "de Kruijf EM" Remove constraint Author: "de Kruijf EM"
23 results on '"de Kruijf EM"'

Search Results

2. The prognostic value of tumor-stroma ratio in tumor-positive axillary lymph nodes of breast cancer patients.

3. Alternatively spliced tissue factor synergizes with the estrogen receptor pathway in promoting breast cancer progression.

5. High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients.

6. Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma.

7. Comparison of frequencies and prognostic effect of molecular subtypes between young and elderly breast cancer patients.

8. The prognostic value of apoptotic and proliferative markers in breast cancer.

9. Tumor immune subtypes distinguish tumor subclasses with clinical implications in breast cancer patients.

10. TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis.

11. Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner.

12. The prognostic role of TGF-β signaling pathway in breast cancer patients.

13. Expression of cell adhesion molecules and prognosis in breast cancer.

14. Hypomethylation of LINE-1 in primary tumor has poor prognosis in young breast cancer patients: a retrospective cohort study.

15. Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients.

16. Primary tumor classification according to methylation pattern is prognostic in patients with early stage ER-negative breast cancer.

17. Age determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancer.

18. NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study.

19. Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10.

20. COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients.

21. Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients.

22. HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients.

23. The predictive value of HLA class I tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancer.

Catalog

Books, media, physical & digital resources